2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

Anderson, Todd J., Grégoire, Jean, Pearson, Glen J., Barry, Arden R., Couture, Patrick, Dawes, Martin, Francis, Gordon A., Genest, Jacques +14 more·2016·Canadian Journal of Cardiology

Cited by (1,000)

Items 601–700 of 1,000

  1. The portfolio dietary pattern and risk of cardiovascular disease mortality during 1988–2019 in US adults: a prospective cohort study
    Meaghan E Kavanagh, Andreea Zurbau, Andrea J. Glenn, Julianah O. Oguntala, Robert G. Josse, Vasanti Malik, Laura Chiavaroli, Simin Liu, Cyril W.C. Kendall, David J.A. Jenkins et al. · 2025 · BMC Medicine
  2. Genetics for the Identification of Lipid Targets Beyond PCSK9
    Linda R. Wang, Robert Alexander Hegele · 2016 · Canadian Journal of Cardiology
  3. Reduction in Serum LDL Cholesterol Using a Nutrient Compendium in Hyperlipidemic Adults Unable or Unwilling to Use Statin Therapy: A Double-Blind Randomized Crossover Clinical Trial
    Stephen Louis Kopecky, Soumya Alias, Elizabeth Klodas, Peter J.H. Jones · 2021 · Journal of Nutrition
  4. Clinical Practice Guidelines Using GRADE and AGREE II for the Impact of Genetic Variants on Plasma Lipid/Lipoprotein/Apolipoprotein Responsiveness to Omega-3 Fatty Acids
    Justine Keathley, Véronique Garneau, Valérie Marcil, David M. Mutch, Julie Robitaille, Iwona Rudkowska, Gabriela Magdalena Sofian, Sophie Desroches, Marie‐Claude Vohl · 2022 · Frontiers in Nutrition
  5. Dietary inflammation and vascular calcification: a comprehensive review of the associations, underlying mechanisms, and prevention strategies
    Xinhai Cui, Wendi Wei, Yuanlong Hu, Zhiyuan Zhang, Mengkai Lu, Yunlun Li, Jibiao Wu, Chao Li · 2024 · Critical Reviews in Food Science and Nutrition
  6. Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults
    Maya S. Safarova, Spencer Frederick Weintraub, Katherine Anais Sadaniantz, Lara C. Kovell, Bruce A. Warden, Michael Seth Garshick, Paul Barton Duell, Eugenia Gianos · 2025 · Current Atherosclerosis Reports
  7. An evaluation of CardioPrevent
    Stéphanie A. Prince, Robert D. Reid, Andrew Pipe, Lisa A. McDonnell · 2017 · Current Opinion in Cardiology
  8. Atherogenic lipid profile and health behaviours in women post-menopause working in agriculture
    Jan Krakowiak, Dorota Raczkiewicz, Artur Wdowiak, Dominika Cichońska, Iwona Bojar · 2019 · Annals of Agricultural and Environmental Medicine
  9. Effect of soluble-viscous dietary fibre on coronary heart disease risk score across 3 population health categories: data from randomized, double-blind, placebo-controlled trials
    Vladimir V.V. Vuksan, John L. Sievenpiper, Elena Jovanovski, Alexandra L. Jenkins, Allison Komishon, Fei Au‐Yeung, Andreea Zurbau, Hoang V. T. Ho, Dandan Li, Lea Smircic Duvnjak · 2020 · Applied Physiology, Nutrition, and Metabolism
  10. Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome
    DAVID H. FITCHETT, Lawrence A. Leiter, Peter Lin, Jennifer Pickering, Robert C. Welsh, James A. Stone, Jean C. Grégoire, Philip A. McFarlane, Anatoly Langer, Anil Kumar Gupta et al. · 2020 · CJC Open
  11. Lipids and lipoproteins
    Leslie J. Donato, Jeffrey W. Meeusen · 2020 · Elsevier eBooks
  12. Strategies for enhancing the initiation of cholesterol lowering medication among patients at high cardiovascular disease risk: a qualitative descriptive exploration of patient and general practitioners’ perspectives on a facilitated relay intervention in Alberta, Canada
    David J.T. Campbell, Rachelle C.W. Lee-Krueger, Kerry McBrien, Todd J. Anderson, Hude Quan, Alexander A. C. Leung, Guanmin Chen, Mingshan Lu, Christopher T Naugler, Sonia Butalia · 2020 · BMJ Open
  13. Statin therapy for patients with aortic stenosis who underwent transcatheter aortic valve implantation: a report from a Japanese multicentre registry
    Fumiaki Yashima, Masahiko Hara, Taku Inohara, Masahiro Jinzaki, Hideyuki Shimizu, Keiichi Fukuda, Makoto Tanaka, Masanori Yamamoto, Yusuke Watanabe, Toru Naganuma et al. · 2021 · BMJ Open
  14. A cross-sectional study evaluating cardiovascular risk and statin prescribing in the Canadian Primary Care Sentinel Surveillance Network database
    Ian S. Johnston, Brendan Miles, Boglárka Soós, Stephanie Garies, Grace Perez, John A. Queenan, Neil Drummond, Alexander G. Singer · 2022 · BMC Family Practice
  15. Diet and vascular risk
    Francisco Gómez-Delgado, Juan Luis Romero‐Cabrera, Pablo Pérez‐Martínez · 2022 · Current Opinion in Cardiology
  16. Nutrition Interventions for Lowering Cardiovascular Risk After Hypertensive Disorders of Pregnancy: A Systematic Review
    M. Macphail, Sonje Juul, Krista Wollny, J. Negre, Amy Metcalfe, Kathleen Helen Chaput, Sonia Butalia, Kara A. Nerenberg · 2023 · CJC Open
  17. Polygenic risk for triglyceride levels in the presence of a high impact rare variant
    Shengjie Ying, Tracy Heung, Bhooma Thiruvahindrapuram, Worrawat Engchuan, Yue Yin, Christina Blagojevic, Zhaolei Zhang, Robert Alexander Hegele, Ryan K. C. Yuen, Anne S. Bassett · 2023 · BMC Medical Genomics
  18. Rational Medical Therapy Is the Key to Effective Cardiovascular Disease Prevention
    John David Spence · 2017 · Canadian Journal of Cardiology
  19. Evolocumab for the treatment of hypercholesterolemia
    Brian Tomlinson, Miao Hu, Yuzhen Zhang, Paul Chan, Zhong-Min Liu · 2017 · Expert Opinion on Biological Therapy
  20. Lipoprotein(a) Levels Are Associated with the Size of Extracranial Arteries in Multiple Sclerosis
    D. Jakimovski, R. Zivadinov, L. Pelizzari, R. Browne, B. Weinstock-Guttman, M. Ramanathan · 2019 · Journal of Vascular Research
  21. Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
    Diana N. Vikulova, I. Skorniakov, Brendon Bitoiu, Chad Brown, Emilie T. Théberge, Christopher B. Fordyce, Gordon A. Francis, Karin H. Humphries, G.B. John Mancini, Simon Neil Pimstone et al. · 2020 · American Journal of Preventive Cardiology
  22. Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers
    Cathy Sun, Diane Brisson, Daniel Gaudet, Teik Chye Ooi · 2020 · Journal of clinical lipidology
  23. Comparison of the Reductions in LDL-C and Non-HDL-C Induced by the Red Yeast Rice Extract Xuezhikang Between Fasting and Non-fasting States in Patients With Coronary Heart Disease
    Liyuan Zhu, Xing-Yu Wen, Qunyan Xiang, Liling Guo, Jin Rui Xu, Shui‐Ping Zhao, Ling Liu · 2021 · Frontiers in Cardiovascular Medicine
  24. Coronary Artery Calcium Score to Refine the Use of PCSK9i in Asymptomatic Individuals: A Multicohort Study
    Miguel Cainzos‐Achirica, Renato Quispe, Reed Mszar, Ramzi Dudum, Mahmoud Al Rifai, Raimund M. Erbel, Andreas Stang, Karl‐Heinz Jöckel, Nils Lehmann, Sara Helena Schramm et al. · 2022 · Journal of the American Heart Association
  25. Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada
    Lachaine, Jean, Charron, Jean-Nicolas, Gregoire, Jean C, Hegele, Robert A, Leiter, Lawrence A · 2023 · ClinicoEconomics and Outcomes Research
  26. The current status of lipoprotein (a) measurement in clinical biochemistry laboratories in the UK: Results of a 2021 national survey
    Saleem Ansari, R. Dermot G. Neely, Jules Payne, Jaimini Cegla · 2023 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
  27. Race/ethnicity and socioeconomic status affect the assessment of lipoprotein(a) levels in clinical practice
    Marianna Pavlyha, Yihao Li, Sarah Crook, Brett R. Anderson, Gissette Reyes‐Soffer · 2024 · Journal of clinical lipidology
  28. Updates on CAD risk assessment: using the coronary artery calcium score in combination with traditional risk factors
    Kiara Rezaie-Kalamtari, Zeinab Norouzi, Alireza Salmanipour, Hossein Mehrali · 2025 · The Egyptian Heart Journal
  29. Cardiovascular Risk Prediction in Older Adults
    Lisandro Damián Colantonio, Vera Bittner · 2025 · Current Atherosclerosis Reports
  30. Causal relationship between circulating lipid traits and periodontitis: univariable and multivariable Mendelian randomization
    Gaofu Hu, Chengjie Song, Yuxuan Yang, Wenhao Wang, Ao Wang, Mei Huang, Lihong Lei, Yanmin Wu · 2023 · Frontiers in Endocrinology
  31. Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention
    Peter Paul Toth, Jean Ferrières, Max Waters, Martin Bødtker Mortensen, Nick S.R. Lan, Nathan D. Wong · 2023 · Frontiers in Cardiovascular Medicine
  32. Effect of Adding Apolipoprotein B Testing on the Prevalence of Dyslipidemia and Risk of Cardiovascular Disease in the Korean Adult Population
    Rihwa Choi, Sang Gon Lee, Eun Hee Lee · 2024 · Metabolites
  33. Cholesterol and Cytokines: Molecular Links to Atherosclerosis and Carcinogenesis
    Varsha Suryan, Nimai Chand Chandra · 2024 · Cell Biochemistry and Biophysics
  34. Strategies for management of patients with elevated lipoprotein(a)
    Charlotte C Ellberg, Harpreet Singh Bhatia · 2024 · Current Opinion in Lipidology
  35. Genetic Testing for Familial Hypercholesterolemia: The Current State of Its Implementation in Canada
    Adam I. Kramer, Susan Christian, Kirsten L. Bartels, Nicol Vaizman, Robert Alexander Hegele, Liam R. Brunham · 2024 · CJC Open
  36. Cholesterol Lowering Guidelines: From Whence We Came and Where We Are Now
    David D. Waters · 2018 · Canadian Journal of Cardiology
  37. Relationship of healthy vascular aging with lifestyle and metabolic syndrome in the general Spanish population. The EVA study
    Marta Gómez‐Sánchez, Leticia Gómez‐Sánchez, María Carmen Patino-Alonso, Rosario Alonso‐Domínguez, Natalia Sánchez‐Aguadero, Jose Ignacio Recio-Rodriguez, Jesús González‐Sánchez, Luis García‐Ortiz, Manuel Ángel Gómez-Marcos · 2020 · Revista Española de Cardiología (English Edition)
  38. Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention
    Zhuoshan Huang, Xing Shui, Yesheng Ling, Linli Zhou, Wenqi Shi, Yanting Luo, Suhua Li, Jieming Zhu, Shujie Yu, Jinlai Liu · 2020 · Clinical Cardiology
  39. Low Density Lipoprotein Cholesterol Targets in Secondary Prevention of Atherosclerotic Cardiovascular Disease.
    Raman Puri, Vimal Mehta, S S Iyengar, S N Narasingan, Paul Barton Duell, Gururaj Balvantrao Sattur, Krishnaswami Vijayaraghavan, Jagdish Chander Mohan, S K Wangnoo, Jamshed J Dalal et al. · 2020 · PubMed
  40. Prevalence and Functional Implication of Silent Coronary Artery Disease in Marathon Runners Over 40 Years of Age: The MATCH-40 Study
    Christopher Thomas Lee, Skyler Eastman, Liane A. Arcinas, Chantal Y. Asselin, David Y. C. Cheung, Andrew Mayba, Antonia Zhu, Jacek Strzelczyk, Bruce Maycher, Brett F. Memauri et al. · 2021 · CJC Open
  41. Guidelines versus trial-evidence for statin use in primary prevention: The Copenhagen General Population Study
    Martin Bødtker Mortensen, Børge Grønne Nordestgaard · 2021 · Atherosclerosis
  42. Influence of cholesterol level on long-term survival and cardiac events after surgical coronary revascularization
    Kevin Lim, Chris Ho Ming Wong, Angel Lok Yiu Lee, Takuya Fujikawa, Randolph H.L. Wong · 2022 · JTCVS Open
  43. Lipoprotein a Combined with Fibrinogen as an Independent Predictor of Long-Term Prognosis in Patients with Acute Coronary Syndrome: A Multi-Center Retrospective Study
    Cai-Yan Cui, Tao Ye, Lian-Chao Cheng, Lin Tong, Lan Tong, Zhen Zhang, Lin Cai · 2022 · Journal of Cardiovascular Development and Disease
  44. Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i
    Erin S. Mackinnon, Bryan Har, Salimah Champsi, Rajvi J. Wani, Lee Geyer, Eileen Shaw, Megan S. Farris, Todd J. Anderson · 2023 · Cardiology and Therapy
  45. Validation of a Case Definition to Identify Patients Diagnosed With Cardiovascular Disease in Canadian Primary Care Practices
    Riddhima Dinah Thomas, Leanne Kosowan, Mary Rose Rabey, Alan Bell, Kim Alexander Connelly, Nathaniel Mark Hawkins, Carolyn Gall Casey, Alexander G. Singer · 2023 · CJC Open
  46. Coronary artery calcium score: we know where we are but not where we may be
    Giulia Mattesi, Maria Teresa Savo, Morena De Amicis, Filippo Amato, Elena Cozza, Simone Corradin, Stefano Da Pozzo, Marco Previtero, Riccardo Bariani, Giorgio De Conti et al. · 2023 · Monaldi Archives for Chest Disease
  47. Prioritising cardiovascular disease risk assessment to high risk individuals based on primary care records
    Ryan Chung, Zhe Xu, Matthew Arnold, David Stevens, Ruth H. Keogh, Jessica Barrett, Hannah Harrison, Lisa A M Pennells, Lois G. Kim, Emanuele Di Angelantonio et al. · 2023 · PLoS ONE
  48. Effects of sumac supplementation on lipid profile: A systematic review and meta‐analysis of randomized controlled trials
    Hossein Bahari, Shaghayegh Taheri, Zahra Namkhah, Hanieh Barghchi, Pishva Arzhang, Elyas Nattagh‐Eshtivani · 2023 · Phytotherapy Research
  49. Statin Prescriptions for High-Risk Patients Are Increased by Laboratory-Initiated Framingham Risk Scores: A Quality-Improvement Initiative
    Christopher T Naugler, Charles Cook, Louise I. Morrin, James C. Wesenberg, Allison A. Venner, Norm R.C. Campbell, Todd J. Anderson · 2017 · Canadian Journal of Cardiology
  50. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease
    Falisha Adatia, Shannon Galway, Maja Grubisić, May Lee, Patrick Daniele, Karin H. Humphries, Tara Sedlak · 2017 · Journal of Women s Health
  51. Effects of fatty acids composition in a breakfast meal on the postprandial lipid responses: a systematic review and meta-analysis of randomised controlled trials
    Yuanhang Yao, Sheri Xueqi Pek, Darel Wee Kiat Toh, Xuejuan Xia, Jung Eun Kim · 2020 · International Journal of Food Sciences and Nutrition
  52. Evaluation of Glycemic Index Education in People Living with Type 2 Diabetes: Participant Satisfaction, Knowledge Uptake, and Application
    Shannan Grant, Andrea J. Glenn, Thomas M. S. Wolever, Robert G. Josse, Deborah L. O’Connor, Alexandra N Thompson, Rebecca Noseworthy, Maxine Seider, Melissa Sobie, Gurita Bhatti et al. · 2020 · Nutrients
  53. Use of Preventive Medications in Patients With Nonobstructive Coronary Artery Disease: Analysis of the PROMISE Trial
    Ricky D. Turgeon, Tara Sedlak · 2020 · CJC Open
  54. Optimum lipid testing for diabetic patients to enhance clinical care
    Sridevi Devaraj, Ishwarlal Jialal · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  55. Cordova Formula for Low-Density Lipoprotein- Cholesterol Estimation: Not Only the Simplest of All But Also Superior to Other Formulae at a Higher Range of Triglyceride
    Sojit Tomo, Shrimanjunath Sankanagoudar, Praveen Sharma · 2022 · The Anatolian Journal of Cardiology
  56. Goal achievement of HbA1c and LDL‐ cholesterol in a randomized trial comparing colesevelam with ezetimibe: GOAL‐RCT
    HARPREET SINGH BAJAJ, Ruth E. Brown, Dishay Jiandani, Karri Venn, Hani Al‐Asaad, Hasnain M. Khandwala, Oren Steen, Suzan Abdel‐Salam, Ronnie Aronson · 2020 · Diabetes Obesity and Metabolism
  57. Lipid-Lowering Therapy for Primary Cardiovascular Prevention in Older Adults. Consensus Statement of the Russian Association of Gerontologists and Geriatricians, National Society on Atherosclerosis, Russian Society of Cardiology, Association of Clinical Pharmacologists
    Yu. V. Kotovskaya, О. Н. Ткачева, И. В. Сергиенко · 2020 · Kardiologiia
  58. How does the TRS 2°P score relate to real-world patients?
    Marc P. Bonaca, Gaetano Maria De Ferrari, Dan Atar, Lori D. Bash, Dominik Lautsch, Erin Ann Bohula, Martin Horack, Philippe Brudi, Jean Ferrières, Anselm Kai Gitt · 2018 · European Heart Journal - Cardiovascular Pharmacotherapy
  59. In Search of Patients With Elevated Lp(a)
    Sotirios Tsimikas · 2019 · Journal of the American College of Cardiology
  60. The Knowledge Assessment of Cardiovascular Disease Risk Factors: A Cross-Sectional Study
    Nora Taiek, Nour El Houda El Fadili, Abderrahmane Belkacem, Attoumane Abdou Cheikh, Kaoutar Kabbadj, Narjisse Damoun, Faiza Aziouaz, Abdelkader Jalil El Hangouche · 2024 · Cureus
  61. Association of helicobacter pylori infection with lipid metabolism and 10-year cardiovascular risk in diabetes mellitus: A cross-sectional study
    Yuexi Li, Xiaoqin Liu, Qing Li, Peng Zhou, Qian Chen, Bolan Jiang, Taiju Zhu · 2025 · PLoS ONE
  62. Metabolomic profiling of a cholesterol lowering plant-based diet from two randomized controlled feeding trials
    Andrea J. Glenn, Anne‐Julie Tessier, Meaghan E Kavanagh, Gloria A. Morgan, Clary B. Clish, Jordi Salas‐Salvadó, Vasanti Malik, Anthony J. Hanley, Richard Paul Bazinet, Elena M. Comelli et al. · 2025 · European Journal of Clinical Nutrition
  63. The interactions of Lipoprotein(a) with common cardiovascular risk factors in cardiovascular disease risk: evidence based on the UK Biobank
    Linjun Ao, Raymond Noordam, J. Wouter Jukema, Diana van Heemst, Ko Willems van Dijk · 2025 · American Journal of Preventive Cardiology
  64. Extreme lipoprotein(a) in clinical practice: A cross sectional study
    Barak Zafrir, Amir Aker, Walid Saliba · 2023 · International Journal of Cardiology Cardiovascular Risk and Prevention
  65. U-shaped association of serum uric acid with cardiovascular disease risk scores and the modifying role of sex among Chinese adults
    Mei Bi, Ao Feng, Yazhuo Liu, Simiao Tian · 2023 · Nutrition Metabolism and Cardiovascular Diseases
  66. A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia
    Eyas Al Mousa, Sayer I. Al-Azzam, Mohammad Araydah, Reema A. Karasneh, Mohammad A. Ghnaimat, Hanna K. Al-Makhamreh, Abdelkarim Khawaldeh, Muneer Ali Abu Al-Samen, JIHAD A. HADDAD, Said Al Najjar et al. · 2023 · Journal of Clinical Medicine
  67. Effect of low-density lipoprotein level and mortality in older incident statin-naïve hemodialysis patients
    Je Hun Song, Eun Hee Park, Jinsuk Bae, Soon Hyo Kwon, Jang‐Hee Cho, Byung Chul Yu, Miyeun Han, Sang Heon Song, Gang-Jee Ko, Jae Won Yang et al. · 2023 · BMC Nephrology
  68. Investigation on the association between serum lipid levels and periodontitis: a bidirectional Mendelian randomization analysis
    Zhi Hong Chen, Jukun Song, Liszen Tang · 2023 · BMC Oral Health
  69. First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults
    Fahimeh Bagherikholenjani, Shahla Shahidi, Golnaz Vaseghi, Vahid Ashoorion, Nizal Sarrafzadegan, Mansour Siavash, Maryam Heidarpour, Shahrzad Shahidi, Masoumeh Sadeghi, Noushin Mohammadifard et al. · 2024 · Journal of Research in Medical Sciences
  70. Remnant cholesterol trajectory and subclinical arteriosclerosis: a 10-year longitudinal study of Chinese adults
    Pingting Yang, Li Ping Tang, Saiqi Yang, Qiuling Shi, Yaqin Wang, Yuexiang Qin, Jiangang Wang, Ying Li · 2024 · Scientific Reports
  71. Simulation model to assess the validity of the clinical portfolio diet score used in the PortfolioDiet.app for dietary self-tracking: a secondary analysis of a randomized controlled trial in hyperlipidemic adults
    Meaghan E Kavanagh, Andrea J. Glenn, Laura Chiavaroli, Gloria A. Morgan, Robert G. Josse, Vasanti Malik, Christopher P. F. Marinangeli, Cyril W.C. Kendall, David J.A. Jenkins, John L. Sievenpiper · 2024 · Frontiers in Nutrition
  72. Factors Associated with Lipoprotein(a) Testing Among Multiethnic Individuals
    Sumeet Brar, Qiwen Huang, Xiaowei Yan, Ramzi Dudum, Powell O. Jose, Ashish Sarraju, Latha P Palaniappan, Fátima Rodríguez · 2024 · Journal of General Internal Medicine
  73. The Paradox of Physical Activity and Coronary Artery Calcification: Implications for Cardiovascular Risk
    Da-Eun Sung, Ki-Chul Sung · 2024 · Journal of Clinical Medicine
  74. A Rare Case of Statin-Induced Necrotizing Autoimmune Myopathy
    Shirley Shuster, Sara Awad · 2020 · AACE Clinical Case Reports
  75. A Patient-Led Referral Strategy for Cardiovascular Screening of Family and Household Members at the Time of Cardiac Intensive Care Unit Admission
    Jonathan Castiel, Annabel Chen‐Tournoux, George Thanassoulis, Michael Goldfarb · 2020 · CJC Open
  76. Projections of incident atherosclerotic cardiovascular disease and incident type 2 diabetes across evolving statin treatment guidelines and recommendations: A modelling study
    Joseph C. Engeda, Stefan K. Lhachimi, Wayne D. Rosamond, Jennifer Leigh Lund, Thomas C. Keyserling, Monika M. Safford, Lisandro Damián Colantonio, Paul Muntner, Christy L. Avery · 2020 · PLoS Medicine
  77. Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure
    Aakash A. Bavishi, Donald M. Lloyd‐Jones, Hongyan Ning, Thanh‐Huyen T. Vu, Clyde W. Yancy, Sanjiv Jayendra Shah, Mercedes R. Carnethon, Sadiya S. Khan · 2020 · PLoS ONE
  78. Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults
    Yi Maggie Guo, Christopher W. Wheldon, Hui Shao, Carl J. Pepine, Eileen Mary Handberg, Elizabeth A. Shenkman, Jiang Bian · 2020 · Journal of the American Heart Association
  79. Does management of lipid lowering differ between specialists and primary care: Insights from GOAL Canada
    Langer, Anatoly, Tan, Mary, Goodman, Shaun G., Grégoire, Jean, Lin, Peter J., Mancini, G. B. John, Stone, James A., Leiter, Lawrence A. · 2021 · International Journal of Clinical Practice
  80. Inverse Association of Poultry, Fish, and Plant Protein Consumption With the Incidence of Cardiovascular Disease
    Steven G. Chrysant, George S. Chrysant · 2021 · Cardiology in Review
  81. Cardioprotective Effects of Nutraceuticals: Focus on Omega-3 Polyunsaturated Fatty Acids
    Grażyna Sypniewska, Stefan Kruszewski · 2021 · Nutrients
  82. Care gaps in achieving cholesterol targets in people with diabetes: A population-based study in a universal health care setting
    Sonia Butalia, Guanmin Chen, Qiuli Duan, Todd J. Anderson · 2021 · Diabetes Research and Clinical Practice
  83. Short-term effects of modest salt reduction combined with DASH diet on changing salt eating habits in hypertensive patients with type II diabetes
    Dan Chen, Jie Tang, Tao Gong, Lisha Mu, Jing Li, Pingping Yu, Hao Wang, Xiaoqing Bu, Lihong Mu, Ying Mei · 2022 · Clinical and Experimental Hypertension
  84. The Impact of Low-Density Lipoprotein Equation Changes on Cholesterol Treatment in Canada
    Pei Zhao, Robert Alexander Hegele · 2022 · CJC Open
  85. Serum lipoprotein(a) predicts 1-year major cardiovascular events in patients after percutaneous coronary intervention.
    Jie Zhang, Mengyu Liu, Misbahul Ferdous, Peng Zhao, Xiujun Li · 2023 · PubMed Central
  86. Antiatherosclerotic Effect and Molecular Mechanism of Salidroside
    Si-Fan Fei, Debing Tong, Fang Jia · 2023 · Reviews in Cardiovascular Medicine
  87. Are Lipid-Lowering and Antihypertensive Medications Used as Complements to Heart-Healthy Diets? A Scoping Review
    Clémence Desjardins, Marie Cyrenne-Dussault, Olivier Barbier, Amélie Bélanger, Anne Gangloff, Line Guénette, Jacinthe Leclerc, Jean Lefèbvre, Arsène Zongo, Jean‐Philippe Drouin‐Chartier · 2023 · Advances in Nutrition
  88. Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United States
    Ana Filipa Fonseca, Hannah Byrne, Andrés Laguna-Fernández, Taha Itani, Rachel L. Studer, Jihaeng Heo, Allison Dillon, Philippe C. Ferber, Madlaina Costa‐Scharplatz · 2023 · Journal of Managed Care & Specialty Pharmacy
  89. Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes
    Gary S. Ma, Tommy T. Chiou, Michael J. Wilkinson · 2023 · Current Cardiology Reports
  90. Comparison of Functional and Morphological Estimates of Vascular Age
    Martin Sigl, LAURA WINTER, GERHARD SCHUMACHER, STEFANIE CHRISTINA HELMKE, Tetyana Shchetynska‐Marinova, Klaus Amendt, Daniel Duerschmied, Anna Lena Hohneck · 2023 · In Vivo
  91. The Minimum Methionine Requirement for Adults Aged ≥60 Years Is the Same in Males and Females
    Alyssa Paoletti, Paul B. Pencharz, Ronald O. Ball, Dehan Kong, Libai Xu, Rajavel Elango, Glenda Courtney‐Martin · 2023 · Nutrients
  92. Relationship Between Diet Quality and Statin Use Among Adults With Metabolic Syndrome From the CARTaGENE Cohort
    Amélie Bélanger, Clémence Desjardins, Lise Leblay, Mathieu Filiatrault, Olivier Barbier, Anne Gangloff, Jacinthe Leclerc, Jean Lefèbvre, Arsène Zongo, Jean‐Philippe Drouin‐Chartier · 2023 · CJC Open
  93. Consideration and Application of Lipoprotein(a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk in Adults
    Tiffany Yuen, G.B. John Mancini, Robert Alexander Hegele, Glen J. Pearson · 2023 · CJC Open
  94. The Canadian Women’s Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 9: Summary of Current Status, Challenges, Opportunities, and Recommendations
    Sharon L. Mulvagh, Tracey J. F. Colella, Martha Gulati, Rebecca Crosier, Saleema Allana, Varinder K. Randhawa, Jill Bruneau, Christine Pacheco, Shahin Jaffer, Lisa M. Cotie et al. · 2023 · CJC Open
  95. Cardiovascular Disease Risk Factor Interventions in Women With Prior Gestational Hypertensive Disorders or Diabetes in North America: A Rapid Review
    Dan Yedu Quansah, Rebekah Lewis, Karine Savard, Laura Alexandra Harris, Sarah May Visintini, Thais A. Coutinho, Kerri‐Anne Mullen · 2023 · CJC Open
  96. Canadian Cost-Effectiveness of Coronary Artery Calcium Screening Based on the Multi-Ethnic Study of Atherosclerosis
    Hena Qureshi, Padma Kaul, Douglas C. Dover, Michael Joseph Blaha, Brandon Kyle Bellows, G.B. John Mancini · 2024 · JACC Advances
  97. Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adults
    Aaron J. Walker, Jianhui Zhu, Floyd W. Thoma, Oscar C. Marroquin, Amber Makani, Martha Gulati, Eugenia Gianos, Salim S. Virani, Fátima Rodríguez, Steven E. Reís et al. · 2024 · American Journal of Preventive Cardiology
  98. Treating Hypercholesterolemia in Older Adults for Primary Prevention of Cardiovascular Events
    Awsse Al-Ani, Yasser Jamil, Ariela R. Orkaby · 2024 · Drugs & Aging
  99. Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management
    G.B. John Mancini, Milan Gupta, Michelle Tsigoulis, Christopher Paul Cannon, Jacques J. Genest, Kausik Kumar Ray, Raul Dias Santos, Gerald Francis Watts, Paolo Raggi · 2017 · Atherosclerosis
  100. Is it time to abandon fasting for routine lipid testing?
    Zareen M. Farukhi, Samia Mora · 2017 · Cleveland Clinic Journal of Medicine